Apremile 20 Tablet contains Apremilast 20 mg, a potent PDE4 inhibitor that acts as an immunomodulator, effectively controlling inflammatory and autoimmune responses. It is primarily used for moderate to severe plaque psoriasis, psoriatic arthritis, and other chronic inflammatory conditions.
By selectively inhibiting PDE4, Apremilast reduces the production of pro-inflammatory cytokines, alleviating skin lesions, joint inflammation, and discomfort. Its oral formulation ensures systemic therapeutic effect with convenient administration.
Clinically, Apremile 20 Tablet is indicated for patients requiring higher-dose therapy for autoimmune and inflammatory disorders, offering sustained symptom relief and improved quality of life.
The tablet formulation provides precise dosing, ease of use, and enhanced patient compliance, making it suitable for hospitals, clinics, and outpatient care for long-term immune management.